Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Drug-induced hepatic diseases].

M Biour1, P Jaillon

  • 1Centre Régional de Pharmacovigilance, Hôpital Saint-Antoine, Paris, France.

Pathologie-Biologie
|December 28, 1999
PubMed
Summary

Drug-induced liver injury is a significant health concern, with over 1000 drugs implicated. Understanding the mechanisms and utilizing classification schemes are crucial for diagnosis and management of these hepatic disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Management of atrial fibrillation in France: the observational FACTUEL study].

Annales de cardiologie et d'angeiologie·2009
Same author

Liver and inflammatory bowel disease.

Gastroenterologie clinique et biologique·2009
Same author

[Hepatic and renal toxicity to fluindione (Previscan)].

Gastroenterologie clinique et biologique·2008
Same author

[Treating heart failure with carvedilol in private practice (initiating treatment and follow-up at one year. The KEOPS study].

Archives des maladies du coeur et des vaisseaux·2007
Same author

Amiodarone interacts with simvastatin but not with pravastatin disposition kinetics.

Clinical pharmacology and therapeutics·2007
Same author

[Flecainide acetate utilisation review among general practitioners and hospital or office-based cardiologists in France. Obepine: observational study of flecainide].

Annales de cardiologie et d'angeiologie·2006

Area of Science:

  • Hepatology
  • Clinical Pharmacology
  • Toxicology

Background:

  • Drug-induced liver injury (DILI) is increasingly recognized as a significant cause of hepatic disorders.
  • Historically underestimated, the contribution of medications to liver damage is now widely acknowledged.
  • Recent advancements have improved understanding of the mechanisms behind DILI.

Purpose of the Study:

  • To summarize current understanding of drug-induced hepatic injury mechanisms.
  • To highlight the diagnostic approach for DILI, emphasizing its similarity to other liver diseases.
  • To introduce the Hepatox computerized database for storing information on drug hepatotoxicity.

Main Methods:

  • Review of scientific literature on drug-induced hepatic injury.
  • Discussion of established mechanisms, including the role of toxic metabolites.
  • Explanation of classification schemes for assessing causality between drugs and liver injury.

Main Results:

  • Over 1000 drugs have been identified as potentially causing hepatic lesions.
  • The diagnostic evaluation for DILI follows standard procedures for liver disease.
  • The Hepatox database serves as a vital resource for accumulating and accessing DILI information.

Conclusions:

  • Drug-induced liver injury is a critical area in hepatology and clinical pharmacology.
  • Accurate diagnosis and management rely on understanding mechanisms and employing classification systems.
  • The Hepatox database is essential for ongoing research and clinical practice related to DILI.

Related Experiment Videos